A Comparison of Scalp Blood Flow and Hair Shaft In Premenopausal Women Versus Postmenopausal Women
NCT ID: NCT01831180
Last Updated: 2018-07-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2013-09-30
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Scalp and Hair Shaft With Biologic Markers in African American and Caucasian Hair
NCT00690664
Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
NCT03711877
Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color
NCT05213936
Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females
NCT06376409
Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers
NCT04626895
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Premenopausal women 19-25 yrs
No interventions assigned to this group
Postmenopausal 60 yrs +
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female in age groups 19-25 years old and 60 years or older
* Must be of Caucasian descent, to avoid any ethnic differences in hair biology or pigment among different races
* Must be willing to have a thorough scalp and hair shaft examination
* Must be willing to discuss current and past hair care regimens
* Must have washed hair at least 48 hours, but not less than 12 hours prior to study visit
* Must be willing to not wash hair between Baseline and second visit.
* Pregnant and nursing females will not be allowed in the study; a baseline pregnancy test will be done to exclude pregnancy on females of childbearing potential
* Must be \>6 months (26 weeks) postpartum
* Must have sufficient contrast between scalp skin color and hair color (Fitzpatrick skin type I-IV)
* Must have hair at least 2 inches long
* May have mild itching and mild scaling of the scalp, but not dandruff
* Must be willing to have hair clipped and shaved to 1 mm within an approximately 1cm2 test site
* Must be a non-smoker for the past 6 months
* Must be in good stable general health, with no current infections
* Must be able to return to the study site 48 hours after the Baseline visit for the second visit.
Exclusion Criteria
* Must not take any antihistamines for two weeks prior to the baseline visit and throughout the study.
* Must not have any known allergy or past history of anaphylaxis to histamine
* May not have sewn-in or glued hair pieces or extensions at the time of the study
* Must not cut hair during the study
* Must not have hair loss beyond what is considered normal in the opinion of the Investigator at the time of the study
* Must not color hair or have other salon-type procedures (relaxer, permanent, highlighting, etc.) performed within 2 weeks of the initial visit
* Must not have any other underlying scalp disorder that could interfere with the test procedures or findings
* Must not have lost ≥10% of body weight within the past 12 months
* Must not have been on a weight reduction program overseen by a physician or nutritionist within the past 12 months
* Has used hair growth products e.g. minoxidil in the past 18 months
* Has undergone a hair transplant or scalp reduction surgery
* Has participated in a hair growth study within the past 15 months
* Is currently participating in another clinical study at this or any other facility
* Is taking, for a chronic condition, any prescription or over the counter medication(s) that in the opinion of the Investigator are likely to affect the hair properties (e.g. immunosuppressive agents, corticosteroids, or chronic use of anti-inflammatory medication)
* Application of any over-the-counter or prescription drug to the scalp on a routine basis within the past 3 months including but not limited to retinoids (e.g. retinal, tretinoin, retinylpalmitate, retinyl acetate, retinyl propionate), topical corticosteroids, benzyl peroxide, or any topical hormone therapy (e.g. Eterna 27)
19 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Procter and Gamble
INDUSTRY
Wake Forest University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amy McMichael, MD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wake Forest School of Medicine - Dermatology Clinic
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00022675
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.